NAFTIFINE

Naftifine is a topical allylamine antifungal that inhibits squalene epoxidase, disrupting ergosterol synthesis in fungal cell membranes. It is used to treat dermatophyte infections like tinea pedis and tinea corporis. Benefits include rapid symptom relief and high local concentrations. Side effects are usually mild and include burning, irritation, dryness, erythema, or pruritus at the application site. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 2a8e5d958d24 Category: Tag:

Product Description


Mechanism of Action

NAFTIFINE exhibits a multivector biochemical action pattern, influencing enzymatic cascades, receptormediated signalling, intracellular ion behaviour, mitochondrial oxidative dynamics and transcriptional regulatory networks. Its structural characteristics suggest interaction with catalytic residues, allosteric pockets and regulatory scaffolds, enabling modulation of phosphorylation circuits, secondmessenger systems (cAMP, Ca²⁺, IP), ROS generation, membrane polarization and metabolicflux channeling.

Depending on biological context, NAFTIFINE may alter mitochondrial membrane potential, redox buffering capacity, calcium sequestration, cytoskeletal integrity, vesicle trafficking efficiency and transcriptionfactor activation, resulting in broad mechanistic adaptability across experimental systems.

Benefits and Advantages

This compound is highly valued in advanced biochemical and pharmacological research frameworks, including:

  • Highresolution receptorligand mapping and affinity prediction
  • Enzymekinetic profiling and catalyticpathway deconstruction
  • Mitochondrialstress testing, ATPflux analysis and ROSequilibrium studies
  • Integrated multiomics research: transcriptomics, metabolomics, proteomics, phosphoproteomics
  • Cytoskeletal modelling involving actin/tubulin regulation
  • Apoptosis, autophagy, necroptosis and ferroptosis signalling investigations
  • Structureactivity relationship (SAR) exploration and molecular optimisation
  • Pharmacodynamic simulations for mechanistic threshold and doseresponse studies

Side Effects and Risks

Possible laboratoryobserved risks include:

  • Redox imbalance with elevated ROS levels
  • Mitochondrial overactivation or respiratorychain suppression
  • Ionchannel dysregulation affecting Na⁺/K⁺/Ca²⁺ flow
  • Crossactivation or inhibition of unintended receptor systems
  • Cytoskeletal destabilisation and impaired membrane integrity
  • Dosedependent cytotoxicity or induction of apoptotic/autophagic pathways
  • Transcriptional instability and activation of inflammatory cascades (NF-κB, JNK, p38)

Strict biosafety handling, controlled dosing and regulated environmental conditions are required for all experimental use. Not intended for human or veterinary application.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H21N

Molecular Weight

287.4 g/mol

CAS Number

65472-88-0

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Naftifine; 65472-88-0; Naftifina; Naftifinum; Naftifin

IUPAC/Chemical Name

(E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine

InChl Key

OZGNYLLQHRPOBR-DHZHZOJOSA-N

InChl Code

InChI=1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+

References

https://pubchem.ncbi.nlm.nih.gov/compound/47641;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download